TMCnet News

Dolby Laboratories Reports Second Quarter Fiscal 2017 Financial Results
[April 26, 2017]

Dolby Laboratories Reports Second Quarter Fiscal 2017 Financial Results


Dolby Laboratories, Inc. (NYSE:DLB) today announced the Company's financial results for the second quarter (Q2) of fiscal 2017. For the second quarter, Dolby reported total revenue of $267.5 million, compared to $274.3 million for the second quarter of fiscal 2016.

Second quarter GAAP net income was $50.6 million, or $0.49 per diluted share, compared to $67.4 million, or $0.66 per diluted share, for the second quarter of fiscal 2016. On a non-GAAP basis, second quarter net income was $65.1 million, or $0.63 per diluted share, compared to $83.5 million, or $0.82 per diluted share, for the second quarter of fiscal 2016. Dolby's non-GAAP measures are described and reconciled to the corresponding GAAP measures at the end of this release.

"We made great progress with our growth initiatives this quarter," said Kevin Yeaman, President and CEO, Dolby Laboratories. "We now have more than 90 Dolby Cinema locations open, up from 20 a year ago. The first smartphone with Dolby Vision was launched by LG and we added two more partners for Dolby Voice, BlueJeans and West."

Dividend

Today, Dolby announced a cash dividend of $0.14 per share of Class A and Class B common stock, payable on May 16, 2017, to stockholders of record as of the close of business on May 8, 2017.

Financial Outlook

Q3 Fiscal 2017

Dolby estimates that total revenue for the third quarter (Q3) of fiscal 2017 will range from $290 million to $305 million. Gross margin percentages are projected to range between 88 percent and 89 percent on a GAAP basis, and between 89 percent and 90 percent on a non-GAAP basis.

Dolby anticipates that operating expenses will be between $176 million and $180 million on a GAAP basis, and between $158 million and $162 million on a non-GAAP basis.

Dolby estimates that diluted earnings per share will be between $0.61 and $0.67 on a GAAP basis, and between $0.75 and $0.81 on a non-GAAP basis.

Dolby estimates that its effective tax rate will be between 24 percent and 25 percent on both a GAAP and non-GAAP basis.

Fiscal Year 2017

Dolby anticipates that total revenue for fiscal 2017 will range from $1.06 billion to $1.10 billion.

Dolby anticipates that operating expenses will range from $696 million to $706 million on a GAAP basis, and from $625 million to $635 million on a non-GAAP basis.

Conference Call Information

Members of Dolby management will lead a conference call open to all interested parties to discuss Q2 fiscal 2017 financial results for Dolby Laboratories at 2:00 p.m. PT (5:00 p.m. ET) on Wednesday, April 26, 2017. Access to the teleconference will be available over the Internet from http://investor.dolby.com/events.cfm or by dialing 1-877-857-6149. International callers can access the conference call at 1-719-325-4878.

A replay of the call will be available from 5:00 p.m. PT on Wednesday, April 26, 2017, until 9:00 p.m. PT on Wednesday, May 3, 2017, by dialing 1-844-512-2921 (international callers can access the replay by dialing 1-412-317-6671) and entering the confirmation code 2767497. An archived version of the teleconference will also be available on the Dolby Laboratories website, http://investor.dolby.com/events.cfm.

Non-GAAP Financial Information

To supplement Dolby's financial statements presented on a GAAP basis, Dolby provides certain non-GAAP financial measures to provide investors with an additional tool to evaluate Dolby's operating results in a manner that focuses on what Dolby's management believes to be its ongoing business operations. Specifically, we exclude the following as adjustments from one or more of our non-GAAP financial measures:

Stock-based compensation expense: Stock-based compensation, unlike cash-based compensation, utilizes subjective and complex assumptions in the methodologies used to value the various stock-based award types that we grant. These assumptions may differ from those used by other companies. To facilitate more meaningful comparisons between our underlying operating results and those of other companies, we exclude stock-based compensation expense.

Expense associated with dividend equivalents paid on restricted stock units: In connection with a special dividend declared in the first quarter of fiscal 2013, we modified restricted stock units (RSUs) that were unvested at that time to preserve their pre-cash dividend economic value. The special dividend was a discrete and infrequent event that is not representative of our normal operating activities; therefore, we exclude the compensation cost related to the dividend equivalents to provide a more accurate view of our underlying operating results.

Amortization of acquisition-related intangibles: We amortize intangible assets acquired in connection with acquisitions. These intangible assets consist of patents and technology, customer relationships, and other intangibles. We record amortization charges relating to these intangible assets in our GAAP financial statements, and we view these charges as items arising from pre-acquisition activities that are determined by the timing and valuation of our acquisitions. As these amortization charges do not directly correlate to our operations during any particular period, and often remain unchanged between reporting periods, we exclude these charges to facilitate an evaluation of our current operating results and comparisons to our past operating performance.

Restructuring charges: Restructuring charges are costs associated with a formal restructuring plan and primarily relate to employee severance benefits and asset impairments. We exclude restructuring costs, including any adjustments to charges recorded in prior periods, as we believe that these costs are not representative of our normal operating activities and therefore, excluding these amounts enables a more effective comparison to our past operating performance.

Income tax adjustments: We believe that excluding the income tax effect of the aforementioned non-GAAP adjustments provides a more accurate view of our underlying operating results to management and investors.

Using the aforementioned adjustments, Dolby provides various non-GAAP financial measures including, but not limited to: non-GAAP net income, non-GAAP diluted earnings per share, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP operating margin, and non-GAAP effective tax rate. Dolby's management believes it is useful for itself and investors to review both GAAP and non-GAAP measures to assess the performance of Dolby's business. Dolby's management does not itself, nor does it suggest that investors should, consider non-GAAP financial measures in isolation from, or as a substitute for, financial information prepared in accordance with GAAP. Whenever Dolby uses non-GAAP financial measures, it provides a reconciliation of the non-GAAP financial measures to the most closely applicable GAAP financial measures. Investors are encouraged to review the related GAAP financial measures and the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measures as detailed above. Investors are also encouraged to review Dolby's GAAP financial statements as reported in its US Securities and Exchange Commission (SEC) filings. A reconciliation between GAAP and non-GAAP financial measures is provided at the end of this press release and on the Dolby Laboratories investor relations website, http://investor.dolby.com.

Forward-Looking Statements

Certain statements in this press release, including, but not limited to, statements relating to Dolby's expected financial results for Q3 fiscal 2017 and fiscal 2017, our ability to advance our long-term objectives and future dividend payments are "forward-looking statements" that are subject to risks and uncertainties. These forward-looking statements are based on management's current expectations, and as a result of certain risks and uncertainties, actual results may differ materially from those projected. The following important factors, without limitation, could cause actual results to differ materially from those in the forward-looking statements: risks associated with trends in the markets in which Dolby operates, including the Broadcast, PC, Consumer Electronics, Mobile, Cinema, and Other Markets; the loss of, or reduction in sales by, a key customer or licensee; pricing pressures; risks associated with the rate at which OEMs include optical disc playback in Windows® devices and the rate of consumer adoption of Windows operating systems; risks that a shift from disc-based media to online media content could result in fewer devices with Dolby® technologies; risks associated with the effects of macroeconomic conditions, including trends in consumer spending; risks relating to the expiration of patents; the timing of Dolby's receipt of royalty reports and payments from its licensees, including back payments; timing of revenue recognition under licensing agreements and other contractual arrangements; Dolby's ability to develop, maintain, and strengthen relationships with industry participants; Dolby's ability to develop and deliver innovative technologies in response to new and growing markets; competitive risks; risks associated with conducting business in China and other countries that have historically limited recognition and enforcement of intellectual property and contractual rights; risks associated with the health of the motion picture industry generally; Dolby's ability to increase its revenue streams and to expand its business generally, and to expand its business beyond audio technologies to other technologies; risks associated with acquiring and successfully integrating businesses or technologies; and other risks detailed in Dolby's SEC filings and reports, including the risks identified under the section captioned "Risk Factors" in its most recent quarterly report on Form 10-Q. Dolby disclaims any obligation to update information contained in these forward-looking statements whether as a result of new information, future events, or otherwise.

About Dolby Laboratories

Dolby Laboratories (NYSE:DLB) creates audio, video, and voice technologies that transform entertainment and communications in mobile devices, at the cinema, at home, and at work. For more than 50 years, sight and sound experiences have become more vibrant, clear, and powerful in Dolby. For more information, please visit www.dolby.com.

Dolby, Dolby Atmos, and the double-D symbol are registered trademarks of Dolby Laboratories. Dolby Cinema and Dolby Vision are trademarks of Dolby Laboratories. All other trademarks remain the property of their respective owners. S15/29000 DLB-F





           
DOLBY LABORATORIES, INC.
INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share amounts)

 
Fiscal Quarter Ended Fiscal Year-To-Date Ended

March 31,
2017

   

April 1,
2016

March 31,
2017

   

April 1,
2016

Revenue: (unaudited)     (unaudited) (unaudited)     (unaudited)
Licensing $ 241,617 $ 249,336 $ 474,316 $ 460,465
Products 20,713 20,063 48,924 44,872
Services 5,144       4,941   10,501       9,817  
Total revenue 267,474       274,340   533,741       515,154  
 
Cost of revenue:
Cost of licensing 8,796 6,698 16,917 13,231
Cost of products 13,988 13,978 31,708 33,016
Cost of services 4,193       3,697   8,319       7,892  
Total cost of revenue 26,977       24,373   56,944       54,139  
               
Gross margin 240,497       249,967   476,797       461,015  
 
Operating expenses:
Research and development 58,341 52,088 115,859 105,416
Sales and marketing 75,620 71,815 146,795 146,269
General and administrative 43,253 42,482 84,793 86,560
Restructuring charges -       1,255   -       1,255  
Total operating expenses 177,214       167,640   347,447       339,500  
               
Operating income 63,283       82,327   129,350       121,515  
 
Other income/expense:
Interest income 2,186 1,250 4,000 2,547
Interest expense (37 ) (33 ) (63 ) (62 )
Other income/(expense), net 762       279   563       (693 )
Total other income 2,911       1,496   4,500       1,792  
               
Income before income taxes 66,194 83,823 133,850 123,307
Provision for income taxes (15,467 )     (16,278 ) (29,549 )     (24,751 )
Net income including controlling interest 50,727 67,545 104,301 98,556
Less: net (income) attributable to controlling interest (137 )     (147 ) (337 )     (257 )
Net income attributable to Dolby Laboratories, Inc. $ 50,590       $ 67,398   $ 103,964       $ 98,299  
 
Net income per share:
Basic $ 0.50 $ 0.67 $ 1.02 $ 0.98
Diluted $ 0.49 $ 0.66 $ 1.00 $ 0.97
Weighted-average shares outstanding:
Basic 101,787 100,456 101,635 100,600
Diluted 103,883 101,555 103,867 101,716
 

         
DOLBY LABORATORIES, INC.
INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands)

 
March 31,
2017
    September 30,
2016
ASSETS (unaudited)
Current assets:
Cash and cash equivalents $ 532,508 $ 516,112
Restricted cash 5,752 3,645
Short-term investments 194,997 121,629
Accounts receivable, net 88,216 75,688
Inventories 17,697 16,354
Prepaid expenses and other current assets 32,501       26,302  
Total current assets 871,671 759,730
Long-term investments 326,800 393,904
Property, plant and equipment, net 471,095 443,656
Intangible assets, net 203,723 215,342
Goodwill 308,751 309,616
Deferred taxes 176,288 166,790
Other non-current assets 29,469       21,068  
Total assets $ 2,387,797       $ 2,310,106  
 
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable $ 10,062 $ 17,544
Accrued liabilities 179,029 169,055
Income taxes payable 25 2,304
Deferred revenue 23,940       24,180  
Total current liabilities 213,056 213,083
Long-term deferred revenue 35,651 35,366
Other non-current liabilities 95,932       82,922  
Total liabilities 344,639 331,371
 
Stockholders' equity:
Class A common stock 57 57
Class B common stock 44 44
Additional paid-in capital 37,459 42,032
Retained earnings 2,013,790 1,938,320
Accumulated other comprehensive (loss) (14,708 )     (10,197 )
Total stockholders' equity - Dolby Laboratories, Inc. 2,036,642 1,970,256
Controlling interest 6,516       8,479  
Total stockholders' equity 2,043,158       1,978,735  
Total liabilities and stockholders' equity $ 2,387,797       $ 2,310,106  
 

     
DOLBY LABORATORIES, INC.
INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

 
Fiscal Year-To-Date Ended

March 31,
2017

    April 1,
2016

Operating activities:

(unaudited)     (unaudited)
Net income including controlling interest $ 104,301 $ 98,556
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization 44,061 42,917
Stock-based compensation 33,198 35,466
Amortization of premium on investments 1,376 2,661
Excess tax benefit from exercise of stock options (3,981 ) (338 )
Provision for doubtful accounts 1,010 1,228
Deferred income taxes (8,856 ) (5,709 )
Other non-cash items affecting net income 160 498
Changes in operating assets and liabilities:
Accounts receivable (13,538 ) (1,727 )
Inventories (3,253 ) (3,533 )
Prepaid expenses and other assets (11,280 ) (6,979 )
Accounts payable and other liabilities 495 (5,939 )
Income taxes, net 11,089 (8,752 )
Deferred revenue 85 8,495
Other non-current liabilities 480       22  
Net cash provided by operating activities 155,347       156,866  
 
Investing activities:
Purchase of investments (98,789 ) (200,944 )
Proceeds from sales of investment securities 23,071 227,094
Proceeds from maturities of investment securities 66,171 59,053
Purchases of PP&E (51,230 ) (48,984 )
Purchase of intangible assets (5,250 ) (105,270 )
Change in restricted cash (2,107 )     (2,342 )
Net cash used in investing activities (68,134 )     (71,393 )
 
Financing activities:
Proceeds from issuance of common stock 24,210 14,575
Repurchase of common stock (50,000 ) (76,856 )
Payment of cash dividend (28,494 ) (24,200 )
Distribution to controlling interest (2,094 ) (214 )
Excess tax benefit from exercise of stock options 3,981 338
Shares repurchased for tax withholdings on vesting of restricted stock (15,799 )     (10,742 )
Net cash used in financing activities (68,196 )     (97,099 )
 
Effect of foreign exchange rate changes on cash and cash equivalents (2,621 )     902  
Net increase/(decrease) in cash and cash equivalents 16,396 (10,724 )
Cash and cash equivalents at beginning of period 516,112       531,926  
Cash and cash equivalents at end of period $ 532,508       $ 521,202  
 

 
GAAP to Non-GAAP Reconciliations

(in millions, except per share data)

         
The following tables present Dolby's GAAP financial measures reconciled to the non-GAAP financial measures included in this release for the second quarter of fiscal 2017 and 2016:
 
Net income: Fiscal Quarter Ended

March 31,
2017

    April 1,
2016
GAAP net income $ 50.6 $ 67.4
Stock-based compensation 15.9 16.1
RSU dividend equivalent - 0.3
Amortization of acquisition-related intangibles 3.8 3.8
Restructuring charges, net - 1.3
Income tax adjustments (5.2 )     (5.4 )
Non-GAAP net income $ 65.1       $ 83.5  
 
Diluted earnings per share: Fiscal Quarter Ended
March 31,
2017
    April 1,
2016
GAAP diluted earnings per share $ 0.49 $ 0.66
Stock-based compensation 0.16 0.16
RSU dividend equivalent - -
Amortization of acquisition-related intangibles 0.03 0.04
Restructuring charges, net - 0.01
Income tax adjustments (0.05 )     (0.05 )
Non-GAAP diluted earnings per share $ 0.63       $ 0.82  
 
Shares used in computing diluted earnings per share 104 102
 
The following tables present a reconciliation between GAAP and non-GAAP versions of the estimated financial amounts for the third quarter of fiscal 2017 and fiscal year 2017 included in this release:
 
Gross margin: Q3 2017
GAAP gross margin (low - high end of range)

88% - 89

%

Stock-based compensation 0.1 %
Amortization of acquisition-related intangibles 0.9 %
Non-GAAP gross margin (low - high end of range)

89% - 90

%

 
Operating expenses: Q3 2017     Fiscal 2017
GAAP operating expenses (low - high end of range) $176 - $180 $696 - $706
Stock-based compensation (17.0 ) (66.0 )
Amortization of acquisition-related intangibles (1.0 )     (5.0 )
Non-GAAP operating expenses (low - high end of range) $158 - $162       $625 - $635  
 
Diluted earnings per share: Q3 2017
Low     High
GAAP diluted earnings per share $ 0.61 $ 0.67
Stock-based compensation 0.16 0.16
Amortization of acquisition-related intangibles 0.03 0.03
Income tax adjustments (0.05 )     (0.05 )
Non-GAAP diluted earnings per share $ 0.75       $ 0.81  
 
Shares used in computing diluted earnings per share 104 104


[ Back To TMCnet.com's Homepage ]